IGF1 and hepatocellular carcinoma: The aims of the current study were 1) to validate the IGF-CTP classification system in patients in a CHB endemic area by comparing the accuracy of the IGF-CTP and the CTP classifications for assessing overall survival (OS) after the first treatment for HCC and 2) to clarify the causes of differences between the predictive values of the classification systems.